Care, Inc.
By:
By:
Print Name:
Print Name:
Title:
Title:
Date:
Date:
26
EXHIBIT A
FORM OF TASK ORDER
Task Order Number [INSERT NUMBER]
to Master Services Agreement Between
Corcept Therapeutics Inc. and Optime Care, Inc.
This Task Order Number [INSERT NUMBER] (the "Task Order") is effective as of
[INSERT DATE] pursuant to, and as a part of, that certain Distribution Services
Agreement (the "Agreement") effective [June 1], 2017 between Corcept
Therapeutics Inc. ("Corcept") and Optime Care, Inc. ("Optime").
Product
For the purposes of this Task Order, "Product" shall mean, Corcept's product
known as [INSERT PRODUCT NAME] and any successor thereto.
Territory:
[INSERT TERRITORY (e.g., United States, European Union, etc.)]
Project Director
[INSERT NAME]
Corcept Representative
[INSERT NAME]
Corcept Personnel
[INSERT THE NUMBER OF PERSONNEL TO BE STAFFED ON THIS PROJECT AND ONLY THE
APPLICABLE POSITION TITLE OF THE PERSONNEL]
SOP(s)and Financial Controls:
[INSERT ALL SOPS AND FINANCIALS CONTROLS APPLICABLE TO THIS PROJECT.]
Services to be Performed:
[INSERT DESCRIPTION OF EACH SERVICE TO BE PERFORMED.]
Project Schedule and Timeline of Services
Target Start Date:
[INSERT DATE]
Target Completion Date (if applicable):
[INSERT DATE, ONLY IF APPLICABLE.]
Services Fees
Deliverables and Delivery Schedule
Optime shall generate and provide to Corcept the following Deliverables:
•[INSERT DELIVERABLE]:
[DELIVERY SCHEDULE; E.G., DAILY/WEEKLY/MONTHLY/
QUARTERLY/ANNUALLY].
A-1
Product Complaint Contact Information
[INSERT APPROPRIATE CORCEPT QA PERSONNEL NAME AND CONTRACT INFORMATION]
Adverse Event Contact Information
[INSERT APPROPRIATE CORCEPT PV PERSONNEL NAME AND CONTRACT INFORMATION]
Other Terms, If Any
(INSERT TERMS, IF ANY]
A-2
In Witness Whereof, the Parties hereto have duly executed this Agreement.
The
Parties acknowledge that the date of signature may not be the Effective Date.
Corcept Therapeutics Inc.
Optime Care, Inc.
By:
By:
Print Name:
Print Name:
Title:
Title:
Date:
Date:
A-3
EXHIBIT B
DISCLOSURE SCHEDULE
1.
Section 13.1(h)(ii).
Letter to Donovan Quill of Optime Care, Inc. from Aaron H.
Kastens of Michael Best & Friedrich LLP, counsel to Dohmen Life Science
Services, LLC, dated February 28, 2017.
2.
Section 13.1(h)(ii).
Letter to Aaron H. Kastens of Michael Best & Friedrich
LLP, counsel to Dohmen Life Science Services, LLC, from Jeffrey L. Schultz,
counsel to Optime Care, Inc., dated March 6, 2017.
B-1